Table 2 Association between LVEF and risk of cardiovascular outcomes.
Outcome | Number of outcome | Follow up, months | IR, per 1000 person-years | Model 1a | Model 2b | ||
|---|---|---|---|---|---|---|---|
HR(95%CI) | p value | HR(95%CI) | p value | ||||
Cardiovascular events | |||||||
55–64% | 634 | 1,130,985 | 6.73 | Ref | Ref | ||
< 55% | 522 | 686,546 | 9.12 | 1.14(1.02,1.28) | 0.027 | 1.15(1.02,1.30) | 0.020 |
≥ 65% | 73 | 99,032 | 8.85 | 1.39(1.09,1.78) | 0.007 | 1.34(1.05,1.72) | 0.018 |
Heart failure | |||||||
55–64% | 54 | 1,130,985 | 0.57 | Ref | Ref | ||
< 55% | 68 | 686,546 | 1.19 | 1.73(1.20,2.48) | 0.003 | 1.69(1.17,2.43) | 0.005 |
≥ 65% | 7 | 99,032 | 0.85 | 1.53(0.69,3.36) | 0.293 | 1.37(0.62,3.02) | 0.439 |
Atrial fibrillation and flutter | |||||||
55–64% | 223 | 1,130,985 | 2.37 | Ref | Ref | ||
< 55% | 195 | 686,546 | 3.41 | 1.20(0.99,1.46) | 0.069 | 1.21(1.00,1.48) | 0.052 |
≥ 65% | 28 | 99,032 | 3.39 | 1.50(1.01,2.23) | 0.043 | 1.46(0.98,2.17) | 0.061 |
Ischemic heart diseases | |||||||
55–64% | 320 | 1,130,985 | 3.40 | Ref | Ref | ||
< 55% | 248 | 686,546 | 4.33 | 1.06(0.90,1.25) | 0.492 | 1.07(0.90,1.27) | 0.434 |
≥ 65% | 42 | 99,032 | 5.09 | 1.63(1.18,2.25) | 0.003 | 1.56(1.13,2.15) | 0.008 |
Myocardial infarction | |||||||
5–64% | 114 | 1,130,985 | 1.21 | Ref | Ref | ||
< 55% | 99 | 686,546 | 1.73 | 1.16(0.88,1.52) | 0.291 | 1.18(0.90,1.55) | 0.230 |
≥ 65% | 16 | 99,032 | 1.94 | 1.79(1.06,3.03) | 0.029 | 1.70(1.00,2.88) | 0.050 |